The IV Passport will help parents and clinicians plan the management of children's multiple vascular access sites.
Griffith has played a key role in a campaign to secure mandatory minimum accessibility standards in the construction industry,to improve the lives of people living with a disability and seniors around Australia.
A team of international scientists has developed an an experimental direct-acting antiviral to treat COVID-19.
Providing food as an intervention to patients in GP and community clinics may help support weight loss a Griffith University study has found.
An international collaboration of researchers from Griffith University’s Menzies Health Institute Queensland, the University of Tartu, the University of Glasgow and the University of Dundee have developed a COVID-19 laboratory research toolkit for sharing with researchers across the globe. Designed to expedite SARS-CoV-2 vaccine development, drug discovery and fundamental research, particularly in laboratories unaccustomed to […]
Griffith University researchers conducting a trial to prevent fractures from osteoporosis are looking for more participants after COVID-19 setbacks.
Cancer, chronic kidney disease, diabetes and hypertension are the four main comorbidities leading to death from COVID-19, a Griffith University meta-analysis published in mBio has found. The researchers analysed global databases MEDLINE, Scopus, Web of Science and EMBASE of 375,859 participants from 14 countries and found chronic kidney disease was statistically the most prominent comorbidity […]